CN103860894B - A kind of medicine for the treatment of chronic prostatitis - Google Patents

A kind of medicine for the treatment of chronic prostatitis Download PDF

Info

Publication number
CN103860894B
CN103860894B CN201410130133.0A CN201410130133A CN103860894B CN 103860894 B CN103860894 B CN 103860894B CN 201410130133 A CN201410130133 A CN 201410130133A CN 103860894 B CN103860894 B CN 103860894B
Authority
CN
China
Prior art keywords
parts
grams
herba
radix
cortex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410130133.0A
Other languages
Chinese (zh)
Other versions
CN103860894A (en
Inventor
宋玉明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410130133.0A priority Critical patent/CN103860894B/en
Publication of CN103860894A publication Critical patent/CN103860894A/en
Application granted granted Critical
Publication of CN103860894B publication Critical patent/CN103860894B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of medicine for the treatment of chronic prostatitis, it is made up of following bulk drugs: Caulis Seu Folium Lespedezae Bicoloris 10 parts, Artemisia eriopoda Bunge. 10 parts, Cortex Lithocarpi Glabri 15 parts, Lignum Cudraniae tricuspidatae 15 parts, Cortex Querci Mongolicae 6 parts, Herba Eupatorii Lindleyani 30 parts, LIUYECAI 6 parts, Rhizoma Polygonati 9 parts, Lysimachia hemsleyana 15 parts, Radix Dipsaci 9 parts, economize 5 parts, rattan, Herba Thlaspis 9 parts, Beesia calthifolia 6 parts, Herba Cichorii 9 parts, Rhizoma Tupistrae Chinensis 9 parts, Cortex Ilicis Rotundae 9 parts, Caulis Bauhihiae Championii 9 parts, Semen Melo 9 parts, Herba seu Radix Calanthes 9 parts, Folium Artemisiae Argyi 9 parts, Herba Corydalis tomentellae 3 parts, Flos Farfarae 5 parts, Herba Pyrolae 9 parts, Radix Arnebiae (Radix Lithospermi) 5 parts, Fructus Dracontomeli Duperreani 3 parts, 9 parts, Semen sojae atricolor, Herba Peristrophes 9 parts, Herba Epimedii 6 parts, Radix Pouzolziae Sanguineae 9 parts, 5 parts, Folium Mori, Semen Sojae Preparatum 6 parts, Flos Gomphrenae 3 parts, Flos Inulae 3 parts, Herba Moslae Soochowensis 3 parts, Fructus Tribuli 6 parts and C. leucophloea 9 parts.The medicament composing prescription for the treatment of chronic prostatitis of the present invention is reasonable, has determined curative effect, safe ready, has no side effect, cheap feature.

Description

A kind of medicine for the treatment of chronic prostatitis
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicine for the treatment of chronic prostatitis.
Background technology
Chronic prostatitis (chronicprostatitis, CP) is Urology Surgery commonly encountered diseases, and the sickness rate of China's chronic prostatitis is more and more higher in recent years, clinical common chronic nonbacterial prostatitis.Because the cause of disease of chronic CP is complicated, and not yet completely clear and definite, so still lack effective medicine.
Summary of the invention
The object of this invention is to provide a kind of medicine for the treatment of chronic prostatitis.
In order to realize object of the present invention, the invention provides a kind of medicine for the treatment of chronic prostatitis, it is made up by weight of following bulk drugs: Caulis Seu Folium Lespedezae Bicoloris 10 parts, Artemisia eriopoda Bunge. 10 parts, Cortex Lithocarpi Glabri 15 parts, Lignum Cudraniae tricuspidatae 15 parts, Cortex Querci Mongolicae 6 parts, Herba Eupatorii Lindleyani 30 parts, LIUYECAI 6 parts, Rhizoma Polygonati 9 parts, Lysimachia hemsleyana 15 parts, Radix Dipsaci 9 parts, economize 5 parts, rattan, Herba Thlaspis (Classification system ThlaspiarvenseL.) 9 parts, Beesia calthifolia 6 parts, Herba Cichorii 9 parts, Rhizoma Tupistrae Chinensis 9 parts, Cortex Ilicis Rotundae 9 parts, Caulis Bauhihiae Championii 9 parts, Semen Melo 9 parts, Herba seu Radix Calanthes 9 parts, Folium Artemisiae Argyi 9 parts, Herba Corydalis tomentellae 3 parts, Flos Farfarae 5 parts, Herba Pyrolae 9 parts, Radix Arnebiae (Radix Lithospermi) 5 parts, Fructus Dracontomeli Duperreani 3 parts, 9 parts, Semen sojae atricolor, Herba Peristrophes 9 parts, Herba Epimedii 6 parts, Radix Pouzolziae Sanguineae 9 parts, 5 parts, Folium Mori, Semen Sojae Preparatum 6 parts, Flos Gomphrenae 3 parts, Flos Inulae 3 parts, Herba Moslae Soochowensis 3 parts, Fructus Tribuli 6 parts and C. leucophloea 9 parts.
Preferably, described medicine can be tablet, dispersible tablet, disintegrating tablet, rapidly dissolving tablet, enteric coatel tablets, washing liquid or decoction.
In order to understand the present invention better, with reference to " Chinese medicine voluminous dictionary " second edition (Shanghai science tech publishing house, 2005), the explanation of some crude drug used in the present invention sees the following form:
Generally acknowledged that " organic conception ", " determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs ", " compound recipe use ", " compound compatibility medication is as used military forces " are the traditional Chinese medical science the most effective most scientific several large advantages at present, wherein " compound compatibility medication is as used military forces " is the original theory of Chinese medicine of very science.The tight compatibility that in traditional Chinese medical science prescription, each medicine is all linked with one another as arrayed troops for battle is that it is better than the effective means of Western medicine formula.Tcm prescription theory is thought, each prescription, not only need to select the appropriate compatibility of suitable medicament according to etiology and pathogenesis, also should meet the basic structure of prescription simultaneously, the i.e. prescription compatibility theory of " monarch, minister, help, make ", the prescription compatibility of so-called " monarch, minister, help, make " is exactly that it is based upon the scientific matching on the comprehensive judgement basis of disease pathogenesis.In medical side by too many levels, Mutiple Targets Integrate adjustment biological mechanism, can to obtain than Western medicine more lastingly, the more therapeutic effect that has no side effect of green natural, and this curative effect be based upon the above-mentioned traditional Chinese medical science tradition original theory accurate instruction on, the present invention just have followed this principle.
For compositions of the present invention, according to the prescription compatibility theory of " monarch, minister, help, make ", Caulis Seu Folium Lespedezae Bicoloris, Artemisia eriopoda Bunge., Cortex Lithocarpi Glabri, Lignum Cudraniae tricuspidatae, Cortex Querci Mongolicae are monarch drug; Herba Eupatorii Lindleyani, LIUYECAI, Rhizoma Polygonati, Lysimachia hemsleyana, Radix Dipsaci, province rattan, Herba Thlaspis, Beesia calthifolia, Herba Cichorii, Rhizoma Tupistrae Chinensis, Cortex Ilicis Rotundae, Caulis Bauhihiae Championii, Semen Melo are ministerial drug; Herba seu Radix Calanthes, Folium Artemisiae Argyi, Herba Corydalis tomentellae, Flos Farfarae, Herba Pyrolae, Radix Arnebiae (Radix Lithospermi), Fructus Dracontomeli Duperreani, Semen sojae atricolor, Herba Peristrophes, Herba Epimedii, Radix Pouzolziae Sanguineae, Folium Mori are adjuvant drug; Semen Sojae Preparatum, Flos Gomphrenae, Flos Inulae, Herba Moslae Soochowensis, Fructus Tribuli and C. leucophloea are for making medicine.All medicines are harmonious in the present invention, reasonable recipe, have determined curative effect, safe ready, have no side effect, cheap feature.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustration of the present invention instead of limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
Take Caulis Seu Folium Lespedezae Bicoloris 10 grams, Artemisia eriopoda Bunge. 10 grams, Cortex Lithocarpi Glabri 15 grams, Lignum Cudraniae tricuspidatae 15 grams, Cortex Querci Mongolicae 6 grams, Herba Eupatorii Lindleyani 30 grams, LIUYECAI 6 grams, Rhizoma Polygonati 9 grams, Lysimachia hemsleyana 15 grams, Radix Dipsaci 9 grams, economize 5 grams, rattan, Herba Thlaspis 9 grams, Beesia calthifolia 6 grams, Herba Cichorii 9 grams, Rhizoma Tupistrae Chinensis 9 grams, Cortex Ilicis Rotundae 9 grams, Caulis Bauhihiae Championii 9 grams, Semen Melo 9 grams, Herba seu Radix Calanthes 9 grams, Folium Artemisiae Argyi 9 grams, Herba Corydalis tomentellae 3 grams, Flos Farfarae 5 grams, Herba Pyrolae 9 grams, Radix Arnebiae (Radix Lithospermi) 5 grams, Fructus Dracontomeli Duperreani 3 grams, 9 grams, Semen sojae atricolor, Herba Peristrophes 9 grams, Herba Epimedii 6 grams, Radix Pouzolziae Sanguineae 9 grams, 5 grams, Folium Mori, Semen Sojae Preparatum 6 grams, Flos Gomphrenae 3 grams, Flos Inulae 3 grams, Herba Moslae Soochowensis 3 grams, Fructus Tribuli 6 grams and C. leucophloea 9 grams, add 1000 milliliters, water, heating 6 hours under the condition of backflow, filter, filtrate is made to be cooled to room temperature, be decoction of the present invention.
Experimental example
Physical data
Be collected in March, 2012 to 2013 year JIUYUE to medical patient 100 example of my institute, age 19-58 year, average 38.6 years old, the course of disease 5 months-6 years, average 2.3 years.Clinical manifestation: frequent micturition, urgent micturition, dysurea, discomfort of urinating, urethra are scratchy, urethra drips white phenomenon or the sound of rain pattering not to the utmost, lower abdomen, perineum, waist sacrum, testis falling inflation are uncomfortable; Wherein 48 examples change with the sexual function such as Erectile Dysfunction, premature ejaculation, seminal emission, painful ejaculation of varying degree, 22 examples with depressed, spirit depressing, insomnia and dreamful sleep, the symptom such as weak.The conventional microscopy of prostatic fluid: leukocyte (+~ +++), lecithin (+~ ++).
Case inclusion criteria
" the Chinese medical disease Standardization of diagnosis and curative effect " promulgated with reference to State Administration of Traditional Chinese Medicine is formulated.(1) frequent micturition, urgent micturition, urine retention, after urine, adularescent secretions overflows, and urinates not smooth, lower abdomen, lumbosacral region, perineum, testis, penis distending pain or discomfort; (2) anus refers to that inspection has prostate to increase, or slightly increases, and quality is comparatively hard or have scleroma, air spots, owes smooth, has tenderness; (3) prostatic fluid microscopy leukocyte >10/HP, lecithin reduces or disappears; (4) prostatic fluid antibacterial culturing is negative.
The decoction prepared in embodiment is used to treat, every day twice, oral 100 milliliters of every day.Continuous treatment 3 weeks.
Criterion of therapeutical effect
The criterion of therapeutical effect of " the new Chinese medicine treatment prostatitis guideline of clinical investigations " formulated with reference to Ministry of Public Health new drug evaluation center (Ministry of Health of the People's Republic of China. new Chinese medicine guideline of clinical investigations (trying) [M]. Beijing China Medical Science Press, 2002.168-172) judge.Cure: NIH-CPSI integration reduces >=90; (2) effective: NIH-CPSI integration reduces 70-89; (3) effective: NIH-CPSI integration reduces 35-69; (4) invalid: NIH-CPSI integration reduces <35 or unchanged.Total effective rate is calculated with healing, effective and effective case.
Result
Result is treated, and finds that the NIH-CPSI integration of 100 routine patients reduces all more than 90.And the prostatic fluid microscopy of all patients does not all find lecithin, lecithin is all labeled as-.

Claims (1)

1. treat the decoction of chronic prostatitis for one kind, it is characterized in that, it is made by following method: take Caulis Seu Folium Lespedezae Bicoloris 10 grams, Artemisia eriopoda Bunge. 10 grams, Cortex Lithocarpi Glabri 15 grams, Lignum Cudraniae tricuspidatae 15 grams, Cortex Querci Mongolicae 6 grams, Herba Eupatorii Lindleyani 30 grams, LIUYECAI 6 grams, Rhizoma Polygonati 9 grams, Lysimachia hemsleyana 15 grams, Radix Dipsaci 9 grams, economize 5 grams, rattan, Herba Thlaspis 9 grams, Beesia calthifolia 6 grams, Herba Cichorii 9 grams, Rhizoma Tupistrae Chinensis 9 grams, Cortex Ilicis Rotundae 9 grams, Caulis Bauhihiae Championii 9 grams, Semen Melo 9 grams, Herba seu Radix Calanthes 9 grams, Folium Artemisiae Argyi 9 grams, Herba Corydalis tomentellae 3 grams, Flos Farfarae 5 grams, Herba Pyrolae 9 grams, Radix Arnebiae (Radix Lithospermi) 5 grams, Fructus Dracontomeli Duperreani 3 grams, 9 grams, Semen sojae atricolor, Herba Peristrophes 9 grams, Herba Epimedii 6 grams, Radix Pouzolziae Sanguineae 9 grams, 5 grams, Folium Mori, Semen Sojae Preparatum 6 grams, Flos Gomphrenae 3 grams, Flos Inulae 3 grams, Herba Moslae Soochowensis 3 grams, Fructus Tribuli 6 grams and C. leucophloea 9 grams, add 1000 milliliters, water, heating 6 hours under the condition of backflow, filter, filtrate is made to be cooled to room temperature and to get final product.
CN201410130133.0A 2014-04-02 2014-04-02 A kind of medicine for the treatment of chronic prostatitis Expired - Fee Related CN103860894B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410130133.0A CN103860894B (en) 2014-04-02 2014-04-02 A kind of medicine for the treatment of chronic prostatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410130133.0A CN103860894B (en) 2014-04-02 2014-04-02 A kind of medicine for the treatment of chronic prostatitis

Publications (2)

Publication Number Publication Date
CN103860894A CN103860894A (en) 2014-06-18
CN103860894B true CN103860894B (en) 2016-03-09

Family

ID=50900281

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410130133.0A Expired - Fee Related CN103860894B (en) 2014-04-02 2014-04-02 A kind of medicine for the treatment of chronic prostatitis

Country Status (1)

Country Link
CN (1) CN103860894B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104784437A (en) * 2015-05-12 2015-07-22 苏海英 Preparation method for medicament for treating chronic prostatitis
CN110613177A (en) * 2019-11-01 2019-12-27 陕西理工大学 Chinese herbal medicine underpants for preventing and treating male prostate and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526642A (en) * 2012-03-20 2012-07-04 南宁市品迪生物工程有限公司 Method for treating prostatitis comprehensively
CN102920833A (en) * 2012-11-05 2013-02-13 张定国 Externally applied medicine for curing prostatitis
CN103301435A (en) * 2013-07-03 2013-09-18 贾东林 Pharmaceutical composition of treating prostatitis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526642A (en) * 2012-03-20 2012-07-04 南宁市品迪生物工程有限公司 Method for treating prostatitis comprehensively
CN102920833A (en) * 2012-11-05 2013-02-13 张定国 Externally applied medicine for curing prostatitis
CN103301435A (en) * 2013-07-03 2013-09-18 贾东林 Pharmaceutical composition of treating prostatitis

Also Published As

Publication number Publication date
CN103860894A (en) 2014-06-18

Similar Documents

Publication Publication Date Title
CN103919940A (en) Chinese medicinal composition for treating hemorrhoid
CN103860894B (en) A kind of medicine for the treatment of chronic prostatitis
CN103705846B (en) The Chinese medicine preparation for the treatment of ovarian cyst
CN102139051A (en) Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia
CN102872362B (en) Traditional Chinese medicine for treating chronic cholecystitis
CN1197614C (en) Chinese medicine cap sule for treating prostatic disorders
CN104013704B (en) Pharmaceutical composition for treating chronic pelvic inflammatory disease and preparation method of composition
CN103341059A (en) Chinese medicine composition for treating non-gonococcal urethritis
CN103721109B (en) A kind of medicament for the treatment of chronic cholecystitis
CN102743686B (en) The scorching clearing capsule of a kind of basin
CN104248725A (en) Traditional Chinese medicine for treating acute gonorrhea
CN104027649A (en) Medicine for treating chronic prostatitis
CN103830679B (en) A kind of medicine and application thereof for the treatment of irritable bowel syndrome
CN104173791A (en) Traditional Chinese medicine for treating acute pyelonephritis
CN103099901A (en) Traditional Chinese medicine enema for treating endometriosis
CN103316238A (en) Traditional Chinese medicine for treating infertility due to cold uterus
CN103330793B (en) Traditional Chinese medicine enema for treating chronic pelvic inflammatory disease
CN102688456B (en) Chinese medicinal composition for treating chronic prostatitis
CN1548065A (en) Compound Chinese medicine for treating chronic pulvic infection and prepn process of its prepn forms
CN102488797B (en) Medicinal composition for treating dysmenorrhea
CN104906441A (en) Traditional Chinese medicine for treating damp-heat pouring downward syndrome non-gonococcal urethritis
CN104784332B (en) A kind of preparation method of the medicament treating Chronic Urinary Tract Infection
CN104208474A (en) Traditional Chinese medicine composition for treating acute urinary tract infection and application thereof
CN104491523A (en) Medicament for treating chronic cholecystitis
CN103550519A (en) Preparation method of medicament for treating dysmenorrhea

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160309

Termination date: 20170402

CF01 Termination of patent right due to non-payment of annual fee